Figure 2
![Figure 2. Clonal architecture inferred from somatic mutations observed in 10 inv(3)/t(3;3) myeloid malignancies. Distribution of estimated VAF determined from whole-exome sequencing. The width of the graph represents the density of mutations with similar VAFs. The yellow dot denotes the VAF of the 3q-aberration [(inv(3)/t(3;3)], the blue dot denotes the VAF of the RAS/RTK-associated mutation, and open circles denote the VAF of all other mutations.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/125/1/10.1182_blood-2014-07-591461/4/133f2.jpeg?Expires=1751414830&Signature=AGuPMIBW-s1K4RKpW3PLabgOXnnBMbSZ7aSO2ChlOgj9NCr8-SSMl2OpsYzDoTX3jDIcuCUYWd3cKsomLLFiCmnvpA9CDpSIwrGWpOYyAfZ1HdIl48tf~Xz4PiAV20N1qE792~zGShK-Zd4PMmDc3SUxp3qql-d-HkRH8qTOZrokzcm9QukfsYsD2CFx0R0jmE3Uu1rguaJhdXYhpb4AUnmWaLdZ8WW0~cmcU56u3tAV2tJxU4WLpwJoNXsEKRAG34szMGKM2avlclJkNQBfqnEfyD~MSTr25qelV7P8dtYq1VKkMEdbgbIBVC~iOaerO48kjNB88C7XynjYAiV0hg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Clonal architecture inferred from somatic mutations observed in 10 inv(3)/t(3;3) myeloid malignancies. Distribution of estimated VAF determined from whole-exome sequencing. The width of the graph represents the density of mutations with similar VAFs. The yellow dot denotes the VAF of the 3q-aberration [(inv(3)/t(3;3)], the blue dot denotes the VAF of the RAS/RTK-associated mutation, and open circles denote the VAF of all other mutations.
